An automated multidimensional screening approach for rapid method development in high performance liquid chromatography.
Despite enormous advancements in the area of high performance liquid chromatography (HPLC) in recent years, method development remains a major challenge. This is primarily due to the unknown nature of the matrix material which sometimes is difficult to characterize (e.g. biological matrices). To improve the efficiency of method development a multidimensional screening approach was presented. This approach was based on two major steps: (1) a matrix spiked with drug was eluted from a large number of columns, each under different mobile phase compositions, to provide the preliminary selectivity-separation information; (2) this information was then used to compose column switching pairs (each pair consisted of a preparatory column followed by an analytical column) and the elution profile was evaluated to determine the suitable clean up and quantitation conditions. An example was provided using ethyl 3,5-bis(acetylamino)-2,4,6-triiodobenzoate (EEDA), an X-ray enhancement agent, in human plasma. Since the HPLC system was fully automated the data generation time, and consequently the method development time, can be significantly reduced.
Wu
D
D
Drug Metabolism and Pharmacokinetics, Nycomed R&D, Wayne, PA 19087, USA.
Berna
M
M
Maier
G
G
Johnson
J
J
D000097:Acetonitriles; D001565:Benzoates / Q000032:analysis; D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation / Q000379:methods*; D005663:Furans; D006801:Humans; D007451:Iodamide / Q000032:analysis; D011838:Radiation-Sensitizing Agents / Q000032:analysis; D015203:Reproducibility of Results
D000097:Acetonitriles; D001565:Benzoates; D005663:Furans; D011838:Radiation-Sensitizing Agents; C111724:ethyl 3,5-bis(acetylamino)-2,4,6-triidobenzoate; C018674:tetrahydrofuran; D007451:Iodamide; C032159:acetonitrile